1.
Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study
by Sandhu, Manjinder S
The Lancet (British edition), 2002, Vol.359 (9319), p.1740-1745
2.
Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targ...
by Betteridge, D. John, MD, PhD
The American journal of cardiology, 2007, Vol.100 (8), p.1245-1248
3.
The Maternal Environment Programs Postnatal Weight Gain and Glucose Tolerance of Male Offspring, but Placental and Fetal Growth Are Determined by Fetal Genotype in the Leprdb/+ Mod...
by Nadif, Raja
Endocrinology (Philadelphia), 2015, Vol.156 (1), p.360-366
4.
Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma
by Westwood, M
Endocrinology (Philadelphia), 1997, Vol.138 (3), p.1130-1136
5.
Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome
by BAJORIA, Rekha
The journal of clinical endocrinology and metabolism, 2001, Vol.86 (7), p.3150-3156
6.
Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: Implications for cardiovascular risk
by Heald, Adrian
Gynecological endocrinology, 2005, Vol.20 (3), p.176-182
7.
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial
by Woodcock, Ashley
The Lancet (British edition), 2017, Vol.390 (10109), p.2247-2255
8.
Type 2 Diabetes Whole-Genome Association Study in Four Populations: The DiaGen Consortium
by Salonen, Jukka T
American journal of human genetics, 2007, Vol.81 (2), p.338-345
9.
The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy
by Westwood, M
The journal of clinical endocrinology and metabolism, 1994, Vol.79 (6), p.1735-1741
10.
Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM)
by Gibson, J. M.
The journal of clinical endocrinology and metabolism, 1996, Vol.81 (2), p.860-863
11.
Placental Regulation of Insulin-Like Growth Factor Axis in Monochorionic Twins with Chronic Twin-Twin Transfusion Syndrome1
by Bajoria, Rekha
The journal of clinical endocrinology and metabolism, 2001, Vol.86 (7), p.3150-3156
12.
Placental Regulation of Insulin-Like Growth Factor Axis in Monochorionic Twins with Chronic Twin-Twin Transfusion Syndrome 1
by Bajoria, Rekha
The journal of clinical endocrinology and metabolism, 2001, Vol.86 (7), p.3150-3156
13.
Purification and Characterization of the Insulin-Like Growth Factor-Binding Protein-1 Phosphoform Found in Normal Plasma1
by Westwood, Melissa
Endocrinology (Philadelphia), 1997, Vol.138 (3), p.1130-1136
14.
Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status
by Westwood, M
The journal of clinical endocrinology and metabolism, 1995, Vol.80 (12), p.3520-3527
15.
Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus
by Gibson, J M
The journal of clinical endocrinology and metabolism, 1995, Vol.80 (4), p.1369-1375
16.
Trace-element speciation and partitioning in environmental geochemistry and health
by Farmer, John G.
Minerals and the Environment, 1983, Vol.5 (2-3), p.57-66
17.
Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants
by Osborne, Nicholas J., PhD
Journal of allergy and clinical immunology, 2011, Vol.127 (3), p.668-676.e2
18.
Significance of False Negative Electrocardiograms in Preparticipation Screening of Athletes for Hypertrophic Cardiomyopathy
by Rowin, Ethan J., MD
The American journal of cardiology, 2012, Vol.110 (7), p.1027-1032
19.
Spectrum and Clinical Significance of Systolic Function and Myocardial Fibrosis Assessed by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
by Olivotto, Iacopo, MD
The American journal of cardiology, 2010, Vol.106 (2), p.261-267
20.
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subje...
by Gibson, C. Michael, MS, MD
The American heart journal, 2014, Vol.169 (4), p.472-478.e5
